Answers are grounded in this paper and cite their sources.
Dicloxacillin is an inducer of CYP2C- and CYP3A-mediated drug metabolism, and we recommend caution when prescribing dicloxacillin to users of drugs with a narrow therapeutic window.
No takes yet. Share an insight, caveat, or question.
Stage et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: